Smith et al., 2025 - Google Patents
Drug resistance-associated mutations in Plasmodium UBP-1 disrupt its essential deubiquitinating activitySmith et al., 2025
View HTML- Document ID
- 2258901390160392484
- Author
- Smith C
- Eavis H
- Briggs C
- Henrici R
- Karpiyevich M
- Ansbro M
- Hoshizaki J
- Ascher D
- Sutherland C
- Lee M
- Artavanis-Tsakonas K
- et al.
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
Deubiquitinating enzymes function to cleave ubiquitin moieties from modified proteins, serving to maintain the pool of free ubiquitin in the cell while simultaneously impacting the fate and function of a target protein. Like all eukaryotes, Plasmodium parasites rely on the …
- 230000035772 mutation 0 title abstract description 52
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4522697B2 (en) | Protease detection system | |
US20190359976A1 (en) | Novel engineered and chimeric nucleases | |
Heuer et al. | Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase− DNA complex | |
AU2002330756A1 (en) | System for detecting protease | |
JPH10501135A (en) | Immunosuppressant target protein | |
US20240016858A1 (en) | Compositions and methods for nucleic acid expression and protein secretion in bacteroides | |
US20120283136A1 (en) | Compositions and methods for the rapid biosynthesis and in vivo screening of biologically relevant peptides | |
US20030153097A1 (en) | Modulation of COP9 signalsome isopeptidase activity | |
US20090238813A1 (en) | Compositions And Methods For Engineered Human Arginine Deiminases | |
Smith et al. | Drug resistance-associated mutations in Plasmodium UBP-1 disrupt its essential deubiquitinating activity | |
Smith et al. | Drug resistance-associated mutations in Plasmodium UBP-1 disrupt ubiquitin hydrolysis | |
EP2064338B1 (en) | A screening method for identifying new aminoacyl-trna synthetase inhibitors | |
US7148018B2 (en) | Protease-activated receptor (par) modulator assays | |
Maragno et al. | FBXO25, an F-box protein homologue of atrogin-1, is not induced in atrophying muscle | |
WO2020165570A1 (en) | Methods relating to disrupting the binding of af9 partner proteins to af9 and/or enl | |
Moyse et al. | The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F1 ATPase | |
WO2020049130A1 (en) | Methods | |
US12258625B2 (en) | Compositions and methods relating to nucleic acid interaction reporters | |
US20230340582A1 (en) | Compositions and methods relating to nucleic acid interaction reporters | |
Patel et al. | In vitro assay for site-specific proteases using bead-attached GFP substrate | |
Bafna et al. | Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir | |
Bolgi | DPP9 substrates in DNA damage repair | |
Palani | Molecular Mechanism of FAM111A, a Dimeric Protease Component of the DNA Damage Response | |
JP2003189884A (en) | New ubiquitin-specific protease | |
Henager | Enzyme-Catalyzed Expressed Protein Ligation |